↓ Skip to main content

Cochrane Database of Systematic Reviews

Risperidone for autism spectrum disorder

Overview of attention for article published in Cochrane database of systematic reviews, January 2007
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs
3 blogs
policy
2 policy sources
twitter
9 tweeters
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
149 Dimensions

Readers on

mendeley
262 Mendeley
citeulike
2 CiteULike
Title
Risperidone for autism spectrum disorder
Published in
Cochrane database of systematic reviews, January 2007
DOI 10.1002/14651858.cd005040.pub2
Pubmed ID
Authors

Ora S Jesner, Mehrnoosh Aref-Adib, Esther Coren

Abstract

Autistic spectrum disorder encompasses a wide variety of behavioural and communicative problems. Both the core features and non-core features of autism have been targeted in a variety of therapies. Atypical antipsychotic medications, including risperidone, have been used for symptom and behaviour improvement and have shown beneficial outcomes, particularly in certain aspects of the disorder. However, given the nature of the condition presenting in young patients, the risks of these potentially long term therapies must be weighed against the benefits.

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 262 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 1%
India 1 <1%
Unknown 258 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 41 16%
Student > Bachelor 33 13%
Researcher 31 12%
Student > Ph. D. Student 19 7%
Other 15 6%
Other 54 21%
Unknown 69 26%
Readers by discipline Count As %
Medicine and Dentistry 85 32%
Psychology 27 10%
Nursing and Health Professions 14 5%
Social Sciences 13 5%
Neuroscience 9 3%
Other 34 13%
Unknown 80 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 36. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 March 2022.
All research outputs
#951,998
of 22,631,715 outputs
Outputs from Cochrane database of systematic reviews
#2,107
of 12,292 outputs
Outputs of similar age
#2,481
of 152,810 outputs
Outputs of similar age from Cochrane database of systematic reviews
#12
of 90 outputs
Altmetric has tracked 22,631,715 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,292 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.2. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 152,810 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 90 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.